Prostatic zinc and prostate specific antigen: an experimental evaluation of their combined diagnostic value.

ABSTRACTPurpose: In cancer affected prostate cells lose the ability to concentrate zinc, resulting in a substantial decrease in Zn in the prostate. We investigated the possibility of using prostatic zinc combined with prostate specific antigen (PSA) as a novel tool for the reliable diagnosis of prostate cancer.Materials and Methods: Using the x-ray fluorescence method the Zn concentration was determined in vitro in prostate samples extracted by surgery from 28 patients. Clinical records included age, serum PSA, sextant prostate needle biopsy, previous medical therapy, surgical procedure and histological findings.Results: A new relationship was found between Zn in prostate tissue and PSA in blood, which allows improved separation between prostate cancer and benign prostate hyperplasia, and might have a significant impact on the reliable diagnosis of prostate cancer.Conclusions: Zn concentration is not uniform even in the same anatomical region of the prostate, so that a number of measurements at various lo...

[1]  A. Breskin,et al.  In vivo determination of prostatic zinc: phantom feasibility study , 2004, Physics in medicine and biology.

[2]  R. Franklin,et al.  Zinc causes a shift toward citrate at equilibrium of the m-aconitase reaction of prostate mitochondria. , 2000, Journal of inorganic biochemistry.

[3]  D. Chan,et al.  Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model. , 1999, Urology.

[4]  R. Franklin,et al.  Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer , 1998, The Prostate.

[5]  I. Romics,et al.  [Zinc, calcium and sodium values in secretions of patients with benign prostatic hyperplasia]. , 1990, Zeitschrift fur Urologie und Nephrologie.

[6]  P. Anthony.  Robbins' Pathologic Basis of Disease , 1990 .

[7]  .. PhD,et al.  Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate , 1989, Cancer.

[8]  R. Lahtonen.  Zinc and cadmium concentrations in whole tissue and in separated epithelium and stroma from human benign prostatic hypertrophic glands , 1985, The Prostate.

[9]  F. Habib,et al.  Cancer of the prostate: early diagnosis by zinc and hormone analysis? , 1979, British Journal of Cancer.

[10]  A. Chowdhury,et al.  Distribution and concentration of zinc in the subcellular fractions of benign hyperplastic and malignant neoplastic human prostate. , 1973, Experimental and molecular pathology.

[11]  K. Min,et al.  Zinc and magnesium in human prostate gland: normal, hyperplastic, and neoplastic. , 1967, Cancer research.

[12]  I. Romics,et al.  Spectrographic determination of zinc in the tissues of adenoma and carcinoma of the prostate , 2005, International Urology and Nephrology.

[13]  R. Wennrich,et al.  Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH) , 2004, Urological Research.

[14]  Jerome P. Richie,et al.  Diagnosis and Staging of Prostate Cancer , 2003 .

[15]  W. Catalona.  Clinical utility of measurement free and total prostate‐specific antigen (PSA): A review , 1996, The Prostate. Supplement.

[16]  R. Franklin,et al.  Concepts of citrate production and secretion by prostate 1. Metabolic relationships , 1991, The Prostate.

[17]  Myron Tanncnbaum,et al.  Urologic pathology: The prostate , 1977 .

[18]  A. Prasad,et al.  Atomic absorption spectrophotometric determination of zinc in the prostate. , 1969, Investigative urology.

[19]  D. Williams.  The male genital tract , 1958 .